Affordable Access

Publisher Website

Late onset Lafora disease and novel EPM2A mutations: Breaking paradigms

Authors
Journal
Epilepsy Research
0920-1211
Publisher
Elsevier
Identifiers
DOI: 10.1016/j.eplepsyres.2014.08.017
Keywords
  • Lafora Disease
  • Atypical Phenotype
  • Epm2A
  • Slow Progression
  • Late Onset
Disciplines
  • Ecology
  • Geography
  • Medicine

Abstract

Summary Lafora disease (LD) is an autosomal recessive progressive myoclonus epilepsy with classic adolescent onset of stimuli sensitive seizures. Patients typically deteriorate rapidly with dementia, ataxia, vegetative failure and death by 25 years of age. LD is caused by homozygous mutations in EPM2A or EPM2B genes. We found four novel mutations in EPM2A – three in exon 4 (Q247X, H265R G279C) and one in exon 1 (Y86D) – and a previously described mutation in exon 4 (R241X). These five EPM2A mutations were found in four index cases and affected relatives. Patient 1 with classic LD was doubly heterozygous for H265R and R241X in exon 4; while Patient 2, who also had classic LD, was homozygous for Q247X in exon 4. Patient 3 with classic LD was homozygous for Y86D in exon 1, but the same mutation in his affected brother manifested an atypical earlier childhood onset. For the first time, we describe a later onset and slower progression of EPM2A-deficient LD seen in Patient 4 and her three sisters who were doubly heterozygous for R241X and G279C in exon 4. In these sisters, seizures started later at 21 to 28 years of age and progressed slowly with patients living beyond 30 years of age. Our observations suggest that variations in phenotypes of EPM2A-deficient LD, like an earlier childhood or adolescent or later adult onset with a rapid or slower course, depend on a second modifying factor separate from pathogenicity or exon location of EPM2A mutations. A modifying gene amongst the patient's genetic background or environmental factors may condition age of onset and rapid or slow progression of LD.

There are no comments yet on this publication. Be the first to share your thoughts.